The association between dietary zinc intake and osteopenia, osteoporosis in patients with rheumatoid arthritis
Authors:
Open Access
- 5 September 2024
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-9
Abstract
Diet has been shown to be associated with rheumatoid arthritis (RA), of which osteoporosis is the most common and important complication, and zinc has been shown to inhibit the inflammatory response, but studies on the relationship between dietary zinc and osteoporosis in patients with RA are limited and inconclusive. In this study, we aimed to explore the relationship between dietary zinc intake and osteoporosis or osteopenia in patients with RA. Data on RA patients were derived from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2010, 2013 to 2014, and 2017 to 2020. Weighted univariate and multivariate logistic regression models were performed to explore the association between dietary zinc intake and osteoporosis or osteopenia in RA patients. The relationship was further investigated in different age, body mass index (BMI), nonsteroidal use, dyslipidemia, diabetes, and hypertension population. All results were presented as odds ratios (ORs) and confidence intervals (CIs). In total, 905 RA patients aged ≥ 40 years were included. After adjusting all covariates, higher dietary zinc intake was associated with lower odds of osteopenia or osteoporosis (OR = 0.39, 95%CI: 0.18–0.86) in RA patients. The relationship between dietary zinc intake ≥ 19.52 mg and lower odds of osteopenia or osteoporosis were also found in those aged ≥ 60 years (OR = 0.38, 95%CI: 0.16–0.91), BMI normal or underweight (OR = 0.16, 95%CI: 0.03–0.84), nonsteroidal use (OR = 0.14, 95%CI: 0.02–0.82), dyslipidemia (OR = 0.40, 95%CI: 0.17–0.92), diabetes (OR = 0.37, 95%CI: 0.14–0.95), and hypertension (OR = 0.37, 95%CI: 0.16–0.86). Higher dietary zinc intake was associated with reduced incidence of osteopenia or osteoporosis in patients with RA. Further longitudinal and randomized trials are necessary to validate our findings and explore the underling mechanisms. Adequate dietary zinc intake may beneficial to the bone health in RA patients.Keywords
This publication has 34 references indexed in Scilit:
- Validity and reliability of an online self-report 24-h dietary recall method (Intake24): a doubly labelled water study and repeated-measures analysisJournal of Nutritional Science, 2019
- [Cross-sectional association between dietary zinc intake and phalangeal osteoporosis].2019
- Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid ArthritisCurrent Rheumatology Reports, 2019
- BMI reduction and vitamin D insufficiency mediated osteoporosis and fragility fractures in patients at nutritional risk: a cross-sectional studyEuropean Journal of Clinical Nutrition, 2018
- Dose–response association of moderate-to-vigorous physical activity with cardiovascular biomarkers and all-cause mortality: Considerations by individual sports, exercise and recreational physical activitiesPreventive Medicine, 2015
- Zinc and its role in immunity and inflammationAutoimmunity Reviews, 2015
- Zinc and its role in age‐related inflammation and immune dysfunctionMolecular Nutrition & Food Research, 2011
- Cell apoptosis induced by zinc deficiency in osteoblastic MC3T3-E1 cells via a mitochondrial-mediated pathwayMolecular and Cellular Biochemistry, 2011
- Role of nutritional zinc in the prevention of osteoporosisMolecular and Cellular Biochemistry, 2009
- Zinc: Its Relationship to Osteoporosis in Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1975